Results 31 to 40 of about 15,525 (208)

Potential prognostic value of PD-L1 and NKG2A expression in Indonesian patients with skin nodular melanoma

open access: yesBMC Research Notes, 2021
Objective Biomarker mRNA levels have been suggested to be predictors of patient survival and therapy response in melanoma cases. This study aimed to investigate the correlations between the mRNA expression levels of PD-L1 and NKG2A in melanoma tissue ...
Ridwan Dwi Saputro   +7 more
doaj   +1 more source

Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer

open access: yesOncoImmunology, 2022
Recently, the inhibitory CD94/NKG2A receptor has joined the group of immune checkpoints (ICs) and its expression has been documented in NK cells and CD8+ T lymphocytes in several cancers and some infectious diseases.
Kathleen Ducoin   +13 more
doaj   +1 more source

Engineered iNKNKG2A KO cells possess HLA-E specific anti-tumor activity [PDF]

open access: yesJichu yixue yu linchuang
Objective To target at the NKG2A-HLA-E inhibitory axis, a pluripotent stem cell(iPSC)-derived genetically engineered natural killer cells(NK cells) with NKG2A knockout (NKG2A KO-iNK) were prepared and then their tumor-killing efficacy was evaluated in ...
QIAO Wenhua, XU Yi, DONG Peng, HE Wei, CHEN Hui, ZHANG Jianmin
doaj   +1 more source

NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells

open access: yesJournal for ImmunoTherapy of Cancer, 2023
Background The natural killer (NK) complex (NKC) harbors multiple genes such as KLRC1 (encoding NKG2A) and KLRK1 (encoding NKG2D) that are central to regulation of NK cell function.
Brwa Ali Hussein   +10 more
doaj   +1 more source

Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy. [PDF]

open access: yes, 2019
Natural killer (NK) cells of the innate immune system are a key focus of research within the field of immuno-oncology based on their ability to recognize and eliminate malignant cells without prior sensitization or priming.
Canter, Robert J   +2 more
core   +2 more sources

Role of NKG2a/c+CD8+ T cells in pathogenic versus non-pathogenic SIV infections

open access: yesiScience, 2021
Summary: Some viruses have established an equilibrium with their host. African green monkeys (AGM) display persistent high viral replication in the blood and intestine during Simian immunodeficiency virus (SIV) infection but resolve systemic inflammation
Nicolas Huot   +11 more
doaj   +1 more source

Effector Functions of Natural Killer Cell Subsets in the Control of Hematological Malignancies. [PDF]

open access: yes, 2015
Treatment of hematological malignant disorders has been improved over the last years, but high relapse rate mainly attributable to the presence of minimal residual disease still persists.
Biassoni   +67 more
core   +1 more source

Memory NK cell features exploitable in anticancer immunotherapy [PDF]

open access: yes, 2019
Besides their innate ability to rapidly produce effector cytokines and kill virus-infected or transformed cells, natural killer (NK) cells display a strong capability to adapt to environmental modifications and to differentiate into long-lived ...
Battella, Simone   +5 more
core   +2 more sources

NKG2A is a NK cell exhaustion checkpoint for HCV persistence [PDF]

open access: yesNature Communications, 2019
AbstractExhaustion of cytotoxic effector natural killer (NK) and CD8+ T cells have important functions in the establishment of persistent viral infections, but how exhaustion is induced during chronic hepatitis C virus (HCV) infection remains poorly defined.
Chao Zhang   +14 more
openaire   +3 more sources

Organ-specific features of natural killer cells. [PDF]

open access: yes, 2011
Natural killer (NK) cells can be swiftly mobilized by danger signals and are among the earliest arrivals at target organs of disease. However, the role of NK cells in mounting inflammatory responses is often complex and sometimes paradoxical.
La Cava, Antonio   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy